Singapore markets closed
Straits Times Index
3,331.70 +5.42 (+0.16%) S&P 500
5,469.30 +21.43 (+0.39%) Dow
39,112.16 -299.05 (-0.76%) Nasdaq
17,717.65 +220.84 (+1.26%) Bitcoin USD
61,373.46 +18.09 (+0.03%) CMC Crypto 200
1,271.89 -11.90 (-0.93%)
Santen Pharmaceutical Co., Ltd. (SNPHY)
OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.66B |
| Enterprise value | 3.07B |
| Trailing P/E | 21.94 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.94 |
| Price/book (mrq) | 1.86 |
| Enterprise value/revenue | 1.62 |
| Enterprise value/EBITDA | 9.66 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.25 |
| 52-week change 3 | 22.34% |
| S&P500 52-week change 3 | 24.96% |
| 52-week high 3 | 10.85 |
| 52-week low 3 | 8.15 |
| 50-day moving average 3 | 10.01 |
| 200-day moving average 3 | 9.64 |
Share statistics
| Avg vol (3-month) 3 | 2.87k |
| Avg vol (10-day) 3 | 420 |
| Shares outstanding 5 | 359.4M |
| Implied shares outstanding 6 | 368.73M |
| Float 8 | 348.73M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 0.02% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.22 |
| Forward annual dividend yield 4 | 2.20% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 2.12 |
| Payout ratio 4 | 22.21% |
| Dividend date 3 | 11 Jul 2019 |
| Ex-dividend date 4 | 28 Sept 2023 |
| Last split factor 2 | 2499:1000 |
| Last split date 3 | 02 Apr 2015 |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 8.82% |
| Operating margin (ttm) | 3.01% |
Management effectiveness
| Return on assets (ttm) | 5.62% |
| Return on equity (ttm) | 8.92% |
Income statement
| Revenue (ttm) | 301.96B |
| Revenue per share (ttm) | 823.04 |
| Quarterly revenue growth (yoy) | -0.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 56.72B |
| Net income avi to common (ttm) | 26.64B |
| Diluted EPS (ttm) | 0.45 |
| Quarterly earnings growth (yoy) | -97.40% |
Balance sheet
| Total cash (mrq) | 94.96B |
| Total cash per share (mrq) | 261.62 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.55 |
| Book value per share (mrq) | 843.19 |
Cash flow statement
| Operating cash flow (ttm) | 72.65B |
| Levered free cash flow (ttm) | 50.53B |
© 2024 Yahoo. All rights reserved.